Sussan Ley has been appointed as the Australian Minister for Health, and replaces Peter Dutton, as part of Prime Minister Tony Abbott's cabinet reshuffle.
Commenting on the appointment, Tim James, chief executive of trade group Medicines Australia said he will be emphasizing the need for a stable and predictable policy environment for biotech and pharma.
Mr James said: “I congratulate Minister Ley on her appointment to a portfolio that directly affects the lives of all Australians. This is a critical time for the medicines industry in Australia, and I’ll be working with the Minister and her office to ensure she is fully briefed on our priority issues. As the peak body representing the research based pharmaceutical industry in Australia, Medicines Australia will be able to offer the new Minister detailed advice on the contribution that innovative medicines make to the Australian community and economy.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze